Statistics for Preclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor
Total visits
| views | |
|---|---|
| Preclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor | 375 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| mtm201311.pdf | 269 |
Top country views
| views | |
|---|---|
| United States | 221 |
| Germany | 53 |
| China | 8 |
| Sweden | 7 |
| France | 5 |
| Ukraine | 5 |
| United Kingdom | 4 |
| Russia | 3 |
| Canada | 2 |
| Finland | 2 |
| Costa Rica | 1 |
| Israel | 1 |
| Italy | 1 |
| Japan | 1 |
| Kazakhstan | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 60 |
| Fairfield | 38 |
| Kiez | 28 |
| Houston | 18 |
| Ann Arbor | 14 |
| Gunzenhausen | 14 |
| Cambridge | 9 |
| Jacksonville | 8 |
| White Plains | 7 |
| Stockholm | 6 |
| Kiev | 5 |
| Endingen | 4 |
| Lake Mary | 4 |
| Nürnberg | 4 |
| Shenzhen | 4 |
| Washington | 4 |
| Falls Church | 3 |
| Munich | 3 |
| Paris | 3 |
| Philadelphia | 3 |
| Saint Petersburg | 3 |
| San Francisco | 3 |
| Alexandria | 2 |
| Brooklyn | 2 |
| Concord | 2 |
| Helsinki | 2 |
| Kansas City | 2 |
| Los Angeles | 2 |
| Toronto | 2 |
| Almaty | 1 |
| Baltimore | 1 |
| Chicago | 1 |
| Chula Vista | 1 |
| Lake Forest | 1 |
| Lexington | 1 |
| Miami | 1 |
| Milan | 1 |
| Motala | 1 |
| Mountain View | 1 |
| Nanterre | 1 |
| Providence | 1 |
| Ramat Hasharon | 1 |
| Roubaix | 1 |
| San José | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Shanghai | 1 |